DAPA most robustly reduced ALT/AST, nearly normalizing values, in line with its hepatoprotective profile and reports of transaminase improvement and safety in steatosis/cirrhosis [18,50], as well as experimental membrane-stabilizing/anti-inflammatory actions [10,24]. This evidence concerns the gene GPT and Cirrhosis.